About Stephen Gunnion Stephen Gunnion is a senior financial journalist and broadcaster at Proactive Investors. He has more than 25…
Read More
Crinetics Pharmaceuticals Announces the European Commission
PALSONIFY is the first once-daily, oral therapy approved to treat acromegaly in the European Union Approval based on strength of…
Read More
CStone Pharmaceuticals Completes HK$1.05 Billion Share Placing to Fund R&D of Pipeline 2.0 Assets – Minichart
CStone Pharmaceuticals Announces Completion of HK\$1.05 Billion Share Placing to Fund R&D Pipeline CStone Pharmaceuticals (Stock Code: 2616), a leading…
Read More
Phathom Pharmaceuticals (PHAT) Is Up 10.0% After Guiding to 2026 Operating Profitability and Raising Capital
In late February 2026, Phathom Pharmaceuticals reported fourth-quarter and full-year 2025 results revealing a much tinyer net loss of US$21.15…
Read More
European pharmaceuticals key to strengthening EU competitiveness
Without the pharmaceutical indusattempt the EU trade balance would go from a surplus of 147 billion euros ($200 billion) to…
Read More
Swiss biotech incubator BaseLaunch bolstered by Takeda Pharmaceuticals partnership
News A Swiss incubator for biotech ventures secured a major boost through a new partnership with the global biopharmaceutical company…
Read More
Is OliX Pharmaceuticals (KOSDAQ:226950) Using Too Much Debt?
Warren Buffett famously declared, ‘Volatility is far from synonymous with risk.’ When we consider about how risky a company is,…
Read More
Employees rally following layoffs at Akorn Pharmaceuticals in Amityville
Hundreds of laid off employees at the Amityville office of Akorn Pharmaceuticals rallied again on Friday. All locations across the…
Read More
Emerging packaging trfinishs in European pharmaceuticals
From smart labelling to eco frifinishly materials, 2026 will see significant shifts in how medicines are protected, traced, and delivered.…
Read More
Phio Pharmaceuticals (PHIO) Stock Skyrockets on Breakthrough Skin Cancer Trial Results – In-Depth Analysis & 2025 Outview
Stock Surge on Trial Breakthrough: Phio Pharmaceuticals’ stock soared over 100% in early trading on November 3, 2025, jumping from…
Read More
